» Articles » PMID: 33660082

Transbronchial Lung Cryobiopsy for Connective Tissue Disease-related Interstitial Lung Disease and Interstitial Pneumonia with Autoimmune Features: a Single Center Retrospective Case Series

Overview
Journal Clin Rheumatol
Publisher Springer
Specialty Rheumatology
Date 2021 Mar 4
PMID 33660082
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Transbronchial lung cryobiopsy (TBLC) has been recently introduced for diagnosing interstitial lung diseases. We aimed to assess the effectiveness and safety of TBLC by identifying the specific patterns of histology in the diagnosis of connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial pneumonia with autoimmune features (IPAF).

Methods: The clinical-radiological-pathological data from the Affiliated Hospital of Guilin Medical University between July 1, 2017, and October 31, 2020, of patients whose clinical-radiological or clinical-radiological-pathological diagnosis was CTD-ILD or IPAF and who underwent TBLC, transbronchial lung biopsy (TBLB), or surgical lung biopsy were retrospectively analyzed and summarized with review. The size of biopsy samples, complications, and diagnostic yield were compared.

Results: Fourteen patients met the inclusion criteria, of whom 12 underwent TBLC, 1 underwent TBLB, and 1 underwent each procedure at different times. Compared to the size of TBLB specimens (5.625 ± 0.479 mm), the size of TBLC specimens (12.00 (12.00, 15.00) mm) was much larger (Z = - 3.262, P = 0.001). The diagnostic yields of TBLC and TBLB were 100.00% (13/13) and 0.00% (2/2), respectively (P = 0.0095). The most frequent complication was mild bleeding. The risk of bleeding between TBLB (1/2, 50.00%) and TBLC (10/13, 76.92%) did not differ significantly (P = 0.469).

Conclusion: TBLC can add extra diagnostic value by effectively identifying specific types of histology for patients with suspected CTD-ILD or IPAF, with a procedure that is safe from adverse events. Key Points • Transbronchial lung cryobiopsy has been introduced recently for diagnosing interstitial lung disease. • Transbronchial lung cryobiopsy was found to be effective and safe in the diagnosis for patients with suspected interstitial lung disease. It can be used as a preferred method for biopsy when the clinical-radiological diagnosis is uncertain.

Citing Articles

Can transbronchial lung cryobiopsy benefit adaptive treatment strategies in connective tissue disease-associated interstitial lung disease?.

Yamakawa H, Takemura T, Sato S, Takatsuka M, Ohta H, Nishizawa T BMC Pulm Med. 2023; 23(1):126.

PMID: 37072760 PMC: 10111663. DOI: 10.1186/s12890-023-02429-0.


Interstitial Pneumonia with Autoimmune Features: What the Rheumatologist Needs to Know.

Joerns E, Adams T, Sparks J, Newton C, Bermas B, Karp D Curr Rheumatol Rep. 2022; 24(6):213-226.

PMID: 35650373 PMC: 9159646. DOI: 10.1007/s11926-022-01072-8.

References
1.
Fischer A, Antoniou K, Brown K, Cadranel J, Corte T, du Bois R . An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J. 2015; 46(4):976-87. DOI: 10.1183/13993003.00150-2015. View

2.
Guo B, Wang L, Xia S, Mao M, Qian W, Peng X . The interstitial lung disease spectrum under a uniform diagnostic algorithm: a retrospective study of 1,945 individuals. J Thorac Dis. 2020; 12(7):3688-3696. PMC: 7399396. DOI: 10.21037/jtd-19-4021. View

3.
Chartrand S, Swigris J, Stanchev L, Lee J, Brown K, Fischer A . Clinical features and natural history of interstitial pneumonia with autoimmune features: A single center experience. Respir Med. 2016; 119:150-154. DOI: 10.1016/j.rmed.2016.09.002. View

4.
Ahmad K, Barba T, Gamondes D, Ginoux M, Khouatra C, Spagnolo P . Interstitial pneumonia with autoimmune features: Clinical, radiologic, and histological characteristics and outcome in a series of 57 patients. Respir Med. 2017; 123:56-62. DOI: 10.1016/j.rmed.2016.10.017. View

5.
McCoy S, Mukadam Z, Meyer K, Kanne J, Meyer C, Martin M . Mycophenolate therapy in interstitial pneumonia with autoimmune features: a cohort study. Ther Clin Risk Manag. 2018; 14:2171-2181. PMC: 6219314. DOI: 10.2147/TCRM.S173154. View